ArticleOncology letters2017

Role and mechanism of decitabine combined with tyrosine kinase inhibitors in advanced chronic myeloid leukemia cells.

Li-Cai Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.